HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bazzie, K. L. Articles by Deffenbaugh, J. Search for Related Content PubMed PubMed Citation Articles by Bazzie, K. L. Articles by Deffenbaugh, J., Jr

KARA L. BAZZIE, PHARM.D., is Pharmacy Resident, Department of Pharmacy, The Johns Hopkins Hospital (JHH), Baltimore, MD. DAVID R. WITMER, PHARM.D., is Vice President, Member Services, American Society of Health-System Pharmacists (ASHP), Bethesda, MD. BRIAN PINTO, PHARM.D., is Drug Information Specialist, JHH. COLLEEN BUSH is Manager, Market Research, ASHP. JOHN CLARK, PHARM.D., M.S., BCPS, is Assistant Director, Pediatric Pharmacy, JHH. JOSEPH DEFFENBAUGH, JR., M.P.H., CAPT, USPHS (RET.), was Director, Public Health and Quality, ASHP.

Address correspondence to Dr. Witmer at the American Society of Health-System Pharmacists, 7272 Wisconsin Avenue, Bethesda, MD 20814 (dwitmer{at}ashp.org).

Purpose. Policies on the use of dietary supplements in acute care facilities were studied. Methods. A national online survey was conducted in 2004 to determine institutional policies and practices related to the use of dietary supplements. Directors of pharmacy in acute care settings were asked about the role of the pharmacy and therapeutics committee, the use of a nonformulary request process, the use of informed consent, requirements for written orders, mechanisms to identify dietary supplements, recording of supplement use in the pharmacy database, recording of supplement use in the medication administration record, prohibitions on dietary supplement use, storage of dietary supplements, reporting of adverse events, and the use of published references. Results. Usable responses were received from 302 (25.4%) of 1189 pharmacy directors. Policies on dietary supplements were developed and implemented in 62% of facilities, with 38% of respondents indicating that no such policy existed. Policies most commonly required a written order by an authorized prescriber, documentation of use in the medication administration record, and a mechanism for identification of dietary supplements by a health care practitioner prior to use. Thirty percent of respondents with policies reported that they prohibited dietary supplement use, and 9% of those without policies prohibited use in practice. Most institutions allowed the use of a patient’s own supply of supplements if ordered by an authorized prescriber. Supplements were most commonly stored at the nurses’ station or in a patient drawer. The most commonly used reference was the Internet. Pharmacists had concerns about the consistency of dietary supplement formulations, the lack of FDA review of supplements, and the difficulty of identifying supplements and distinguishing reputable manufacturers. Conclusion. A survey of pharmacy directors in acute care facilities revealed that many had no formal policy regarding dietary supplements and had not implemented planning for such a policy. Index terms: Administration; Control, quality; Data collection; Documentation; Drugs, adverse reactions; Formulations; Internet; Medication orders; Pharmacists; Pharmacy and therapeutics committee; Pharmacy, institutional, hospital; References; Reports; Storage

 

This article has been cited by other articles:

				P. Gardiner, R. S. Phillips, K. J. Kemper, A. Legedza, S. Henlon, and A. D. Woolf Dietary Supplements: Inpatient Policies in US Children's Hospitals Pediatrics, April 1, 2008; 121(4): e775 - e781. [Abstract] [Full Text] [PDF]